Michael Li, MD, MPH


My research focuses on the relationship between the immune system and liver disease. In addition to studying autoimmune diseases such as primary sclerosing cholangitis, I investigate the use of immunotherapy in liver cancer. My goal is to improve cirrhosis cancer patient outcomes by identifying those with the most to gain and the least risk from immunotherapy through discovering clinical predictors and biomarkers of treatment response and treatment toxicity.

I earned his medical degree at the Icahn School of Medicine at Mount Sinai and completed a residency in internal medicine at the Mount Sinai Hospital. I completed a fellowship in gastroenterology at Brigham and Women’s Hospital, during which I also earned his MPH degree from the Harvard TH Chan School of Public Health. I then completed a fellowship in transplant hepatology at UCSF before becoming a faculty member in the UCSF Division of Gastroenterology and Hepatology.